Botox Shots Thwart Some Forms of Migraine Headaches

A pilot study indicated that the same form of botulinum shot employed for age-defying treatments could be linked to lowered occurrences of migraine headaches which are illustrated as severe, vice-similar or ocular (eye-exploding) types, however not for pains which are sensed as a kind of pressure building up within the head.

Migraine headaches affect nearly twenty-eight million people in the United States and mostly cause incapacitating pain, according to backdrop data in the current month’s editorial ‘Archives of Dermatology’.

Investigators performed quantifiable studies on botulinum toxin type A for treating age lines on the face, identified an association in-between botox shots and the allaying of migraine signs. The authors wrote that the preliminary outcomes guarantee of a novel preventative treatment for migraines being encountered. However, consequent studies have not been successful in demonstrating that botulinum had greater efficacy as compared to the placebo.

Investigators have scrutinized for patient features which could forecast a positive cure response.

Researchers conducted a study on eighteen patients averaging fifty years old that had been previously administered or were intending on receiving botox shots for aesthetic reasons however additionally cited suffering from migraines. From them, ten cited imploding or severe or ocular types of headaches, cited feeling alike an object being prodded into the eyes. 9 of the patients experienced splitting or exploding types of headaches or that of pressure build-up occurring. A number of patients experienced over one form of headache.

3 months following treatment, thirteen patients showed positive response to the treatment with lowered migraine headaches, inclusive of ten whom had ocular headaches and 3 patients that were having splitting headaches. All 6 of the patients not responding to the treatment had splitting headaches.

Amongst all entrants that showed response to botox shots, migraine regularity was lowered from nearly 7 days on a monthly (average) to a day every month.

Entrants having exploding headaches sensed reduced incidence of migraine from nearly eleven days to nine days in each month, while regularity of those entrants having ocular headaches decreased from seven days each month to a day per month.

Botox that is responsible for paralysing muscle is not the sole explanation on how it prevents migraine pain. Studies suggest that it could be affecting the manner in which pain signalling pass through the nervous system, obstruct pain receptors or lower inflammation.

The outcomes of this pilot study offer backing to the conjecture that patients having migraine headaches typified by ocular and imploding types of headaches show better response to botox shots as compared to those people having splitting form of headaches. The authors have mentioned that further well-controlled studies would be needed for confirming such findings.

Popularity: 5% [?]